Recombinant fragment of human surfactant protein D to prevent neonatal chronic lung disease (RESPONSE): a protocol for a phase I safety trial in a tertiary neonatal unit (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2024-086394
Publication URI: http://dx.doi.org/10.1136/bmjopen-2024-086394
Type: Journal Article/Review
Parent Publication: BMJ Open
Issue: 8